![Chenyang Shi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chenyang Shi
Director/Board Member at GENSCRIPT BIOTECH CORPORATION
Profile
Chenyang Shi was the founder of NuProbe USA, Inc., a company founded in 2016, where he held the title of Chief Executive Officer.
He is currently working as an Independent Non-Executive Director at Genscript Biotech Corp.
since 2024.
Dr. Shi has a graduate and doctorate degree from Rochester Christian University.
He also holds an undergraduate degree from the University of Science & Technology of China, which he received in 1986.
Chenyang Shi active positions
Companies | Position | Start |
---|---|---|
GENSCRIPT BIOTECH CORPORATION | Director/Board Member | 12/04/2024 |
Former positions of Chenyang Shi
Companies | Position | End |
---|---|---|
NuProbe USA, Inc.
![]() NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Founder | - |
Training of Chenyang Shi
Rochester Christian University | Doctorate Degree |
University of Science & Technology of China | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GENSCRIPT BIOTECH CORPORATION | Health Technology |
Private companies | 1 |
---|---|
NuProbe USA, Inc.
![]() NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Chenyang Shi